Abstract
The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Current Genomics
Title: ras Genes and Human Cancer: Different Implications and Different Roles
Volume: 3 Issue: 4
Author(s): Jose M. Rojas and Eugenio Santos
Affiliation:
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Abstract: The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Export Options
About this article
Cite this article as:
Rojas M. Jose and Santos Eugenio, ras Genes and Human Cancer: Different Implications and Different Roles, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350381
DOI https://dx.doi.org/10.2174/1389202023350381 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Carbohydrate Mimotopes in the Rational Design of Cancer Vaccines
Current Topics in Medicinal Chemistry Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology The Stress Rheostat: An Interplay Between the Unfolded Protein Response (UPR) and Autophagy in Neurodegeneration
Current Molecular Medicine The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued) Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets The Wnt Pathway in Mood Disorders
Current Neuropharmacology Role of Sirtuins and Calorie Restriction in Neuroprotection: Implications in Alzheimers and Parkinsons Diseases
Current Pharmaceutical Design Rab5 in the Regulation of Cell Motility and Invasion
Current Protein & Peptide Science Suicidal Inactivation of Methemoglobin by Generation of Thiyl Radical: Insight into NAC Mediated Protection in RBC
Current Molecular Medicine Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology A Quantitative Proteomic Analysis to Reveal Effects of N-acetylcysteine on H<sub>2</sub>O<sub>2</sub>-induced Cytotoxicity
Current Proteomics Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry The Ligand Binding Region of the Sigma-1 Receptor: Studies Utilizing Photoaffinity Probes, Sphingosine and N-Alkylamines
Current Pharmaceutical Design Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review
Current Drug Targets Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer
Current Genomics